Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022 – 2033
2.3 Market Size & Forecast, By Segmentation, 2022 – 2033
2.3.1 Market Size By Treatment
2.3.2 Market Size By Administration
2.3.3 Market Size By Type
2.3.4 Market Size By Distribution Channel
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Pricing Analysis & Forecast
4.1.1 Overview
4.1.2 Average Treatment Cost per Patient (Branded vs. Generic Drugs)
4.1.3 Pricing Models: Out-of-Pocket vs. Insurance-Covered
4.1.4 Price Benchmarking by Key Pharmaceutical Companies
4.1.5 Forecasted Price Trends: Emerging Biologics and Novel Formulations
4.2 Regulatory & Approval Landscape
4.2.1 Overview
4.2.2 FDA, EMA, and Other Regional Approvals of Postpartum Depression Drugs
4.2.3 Orphan Drug Designations & Incentives for PPD Therapies
4.2.4 Compliance with Safety and Clinical Trial Guidelines
4.2.5 Future Regulatory Outlook: Fast-Track Approvals and Pediatric/Neonatal Safety
4.3 Pipeline & R&D Metrics
4.3.1 Overview
4.3.2 Number of Drugs in Clinical Trials (Phase I, II, III)
4.3.3 Average Time from Discovery to Approval (Years)
4.3.4 Success Rate by Drug Class (SSRIs, SNRIs, Novel Therapeutics)
4.3.5 Number of Orphan Drug Candidates in PPD Pipeline
4.4 Treatment Adoption & Utilization
4.4.1 Overview
4.4.2 Prescription Rate by Drug Class (%)
4.4.3 Patient Adherence & Dropout Rates (%)
4.4.4 Share of Hospital vs. Outpatient Prescriptions
4.4.5 Rate of Switching from Traditional Antidepressants to Novel Therapies
5. Postpartum Depression Drugs Market Segmental Analysis & Forecast, By Treatment, 2022 – 2033, Value (USD Million)
5.1 Introduction
5.2 Pharmacotherapy
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2033
5.3 Hormonal Therapy
5.4 Others
6. Postpartum Depression Drugs Market Segmental Analysis & Forecast, By Administration, 2022 – 2033, Value (USD Million)
6.1 Introduction
6.2 Parenteral
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2033
6.3 Oral
6.4 Others
7. Postpartum Depression Drugs Market Segmental Analysis & Forecast, By Type, 2022 – 2033, Value (USD Million)
7.1 Introduction
7.2 Postpartum Blues
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2033
7.3 Postpartum Anxiety
7.4 Postpartum Obsessive-Compulsive Disorder (OCD)
7.5 Postpartum Post-Traumatic Stress Disorder (PTSD)
7.6 Postpartum Panic Disorder
7.7 Postpartum Psychosis
8. Postpartum Depression Drugs Market Segmental Analysis & Forecast, By Distribution Channel, 2022 – 2033, Value (USD Million)
8.1 Introduction
8.2 Hospital Pharmacy
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022 – 2033
8.3 Retail Pharmacy
8.4 Others (online pharmacy)
9. Postpartum Depression Drugs Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Million)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Postpartum Depression Drugs Market Size & Forecast, By Treatment, 2022 – 2033
9.2.3 Postpartum Depression Drugs Market Size & Forecast, By Administration, 2022 – 2033
9.2.4 Postpartum Depression Drugs Market Size & Forecast, By Type, 2022 – 2033
9.2.5 Postpartum Depression Drugs Market Size & Forecast, By Distribution Channel, 2022 – 2033
9.2.6 Postpartum Depression Drugs Market Size & Forecast, By Country, 2022 – 2033
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Postpartum Depression Drugs Market Size & Forecast, By Treatment, 2022 – 2033
9.3.3 Postpartum Depression Drugs Market Size & Forecast, By Administration, 2022 – 2033
9.3.4 Postpartum Depression Drugs Market Size & Forecast, By Type, 2022 – 2033
9.3.5 Postpartum Depression Drugs Market Size & Forecast, By Distribution Channel, 2022 – 2033
9.3.6 Postpartum Depression Drugs Market Size & Forecast, By Country, 2022 – 2033
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Postpartum Depression Drugs Market Size & Forecast, By Treatment, 2022 – 2033
9.4.3 Postpartum Depression Drugs Market Size & Forecast, By Administration, 2022 – 2033
9.4.4 Postpartum Depression Drugs Market Size & Forecast, By Type, 2022 – 2033
9.4.5 Postpartum Depression Drugs Market Size & Forecast, By Distribution Channel, 2022 – 2033
9.4.6 Postpartum Depression Drugs Market Size & Forecast, By Country, 2022 – 2033
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Postpartum Depression Drugs Market Size & Forecast, By Treatment, 2022 – 2033
9.5.3 Postpartum Depression Drugs Market Size & Forecast, By Administration, 2022 – 2033
9.5.4 Postpartum Depression Drugs Market Size & Forecast, By Type, 2022 – 2033
9.5.5 Postpartum Depression Drugs Market Size & Forecast, By Distribution Channel, 2022 – 2033
9.5.6 Postpartum Depression Drugs Market Size & Forecast, By Country, 2022 – 2033
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Postpartum Depression Drugs Market Size & Forecast, By Treatment, 2022 – 2033
9.6.3 Postpartum Depression Drugs Market Size & Forecast, By Administration, 2022 – 2033
9.6.4 Postpartum Depression Drugs Market Size & Forecast, By Type, 2022 – 2033
9.6.5 Postpartum Depression Drugs Market Size & Forecast, By Distribution Channel, 2022 – 2033
9.6.6 Postpartum Depression Drugs Market Size & Forecast, By Country, 2022 – 2033
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 Egypt
9.6.6.5 South Africa
9.6.6.6 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Sage Therapeutics, Inc.
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Pfizer Inc.
10.6.3 Eli Lilly and Company
10.6.4 GlaxoSmithKline plc
10.6.5 Merck & Co., Inc.
10.6.6 Biogen Inc.
10.6.7 Bausch Health Companies Inc.
10.6.8 Cipla Ltd
10.6.9 Novartis AG
10.6.10 Teva Pharmaceutical Industries Ltd.
10.6.11 Sanofi S.A.
10.6.12 Johnson & Johnson (Janssen Pharmaceuticals)
10.6.13 AstraZeneca plc
10.6.14 Takeda Pharmaceutical Company Limited
10.6.15 Sun Pharmaceutical Industries Ltd.
10.6.16 H. Lundbeck A/S
10.6.17 Mylan N.V. (Viatris)
10.6.18 Aurobindo Pharma
10.6.19 Lupin Ltd
10.6.20 Accord Healthcare
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
